What is the Sk Bioscience Co., Ltd. stock price forecast?

Sk Bioscience Co., Ltd. is currently trading at ₩43,050. View real-time AI analysis on Alpha Lenz.

What is Sk Bioscience Co., Ltd. insider trading activity?

View the latest insider trading data for Sk Bioscience Co., Ltd. on Alpha Lenz.

What is Sk Bioscience Co., Ltd.'s P/E ratio?

Sk Bioscience Co., Ltd.'s P/E ratio is -61.7.

Sk Bioscience Co., Ltd.

KRX · 302440

₩43,050

Ask about Sk Bioscience Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Sk Bioscience Co., Ltd. trades at a P/E of -61.7 (undervalued) with modest ROE of -3.1%.”

Ask for details →

Company Overview

Sk Bioscience Co., Ltd. is a South Korean biopharmaceutical company that specializes in the development, manufacturing, and distribution of vaccines. As a key player in the healthcare sector, the company's primary focus is on providing high-quality vaccines that address various infectious diseases globally. Sk Bioscience Co., Ltd. is renowned for its advanced research and development capabilities, which have positioned it at the forefront of the vaccine industry. Its portfolio includes a range of products for both the domestic and international markets, supported by state-of-the-art production facilities and rigorous compliance with international quality standards. The company's strategic partnerships with global health organizations and its commitment to innovation underscore its influential role in advancing public health through preventive care solutions. Operating within the dynamic life sciences industry, Sk Bioscience Co., Ltd. continues to contribute significantly to the development and accessibility of essential vaccines worldwide.

CEO안재용

Websitehttps://www.skbioscience.co.kr

SectorHealthcare

IndustryBiotechnology

Employees917

Company Statistics

FY 2024

Profile

₩3,377,554,606,650Market Cap

₩267,545,049,150Revenue

78.46MShares Out

917Employees

Margins

11.58%Gross

-23.84%EBITDA

-51.74%Operating

-33.31%Pre-Tax

-18.73%Net

Valuation

-61.68P/E

1.84P/B

12.42EV/Sales

-56.81EV/EBITDA

-11.07P/FCF

Growth (CAGR)

-33.96%Rev 3Yr

7.78%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-2.13%ROA

-3.07%ROE

-3.64%ROIC

Financial Health

₩312,701,506,490Cash & Cash Equivalents

₩508,442,352,820Net Debt

40.60%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Sk Bioscience Co., Ltd. trades at a P/E of -61.7 (undervalued) with modest ROE of -3.1%.”

Ask for details →

Frequently Asked Questions

Sk Bioscience Co., Ltd. (ticker: 302440) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 917 employees. Market cap is $3.4T.

The current price is ₩43,050 with a P/E ratio of -61.68x and P/B of 1.84x.

ROE is -3.07% and operating margin is -51.74%. Annual revenue is $267.5B.